Age-dependent alterations of the hippocampal cell composition and proliferative potential in the hAβPPSwInd-J20 mouse

Journal of Alzheimer's Disease

Volumn 41, Issue 4, 2014, Pages 1177-1192

  Fu, YuHong ^a,b   Rusznák, Zoltán ^a   Kwok, John B J ^a,b   Kim, Woojin Scott ^a,b   Paxinos, George ^a,b  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Alzheimer's disease; cellular constituents; hippocampus; J20; microglia; neurogenesis; proliferation

Indexed keywords

AMYLOID PRECURSOR PROTEIN; KI 67 ANTIGEN; DOUBLECORTIN PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; NERVE PROTEIN; NEUROPEPTIDE;

AGE; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; ASTROCYTE; CELL COMPOSITION; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; DENTATE GYRUS; GENETIC ASSOCIATION; HIPPOCAMPUS; MALE; MICROGLIA; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; TRANSGENE; WILD TYPE; AGING; ALZHEIMER DISEASE; ANIMAL; C57BL MOUSE; CELL DEATH; DISEASE MODEL; GENETICS; GLIA; HUMAN; METABOLISM; MUTATION; PATHOLOGY; TRANSGENIC MOUSE;

AGE FACTORS; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CELL DEATH; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; HUMANS; IN SITU NICK-END LABELING; KI-67 ANTIGEN; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROTUBULE-ASSOCIATED PROTEINS; MUTATION; NERVE TISSUE PROTEINS; NEUROGLIA; NEUROPEPTIDES;

EID: 84922727888     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-132717     Document Type: Article

References (65)

1. Nelson PT, Braak H, MarkesberyWR(2009) Neuropathology and cognitive impairment in Alzheimer disease: A complex but coherent relationship. J Neuropathol Exp Neurol 68, 1-14.
2. Blennow K, de Leon MJ, Zetterberg H (2006) Alzheimer's disease. Lancet 368, 387-403.
3. Ittner LM, Götz J (2011) Amyloid-beta and tau-a toxic pas de deux in Alzheimer's disease. Nat Rev Neurosci 12, 65-72.
4. Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu GQ, Mucke L (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 316, 750-754.
5. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297, 353-356.
6. Ghosal K, Stathopoulos A, Pimplikar SW (2010) APP intracellular domain impairs adult neurogenesis in transgenic mice by inducing neuroinflammation. PLoS One 5, e11866.
7. Stein TD, Anders NJ, DeCarli C, Chan SL, Mattson MP, Johnson JA (2004) Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSW mice resulting in tau phosphorylation and loss of hippocampal neurons: Support for the amyloid hypothesis. J Neurosci 24, 7707-7717.
8. Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8, 101-112.
9. Selkoe DJ (2000) Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann N Y Acad Sci 924, 17-25.
10. Sisodia SS, St George-Hyslop PH (2002) gamma-Secretase, Notch, Abeta and Alzheimer's disease: Where do the presenilins fit in? Nat Rev Neurosci 3, 281-290.
11. Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, de Souza LC, Stern Y, Visser PJ, Scheltens P (2010) Revising the definition of Alzheimer's disease: A new lexicon. Lancet Neurol 9, 1118-1127.
12. BennettDA, Schneider JA, Arvanitakis Z,Kelly JF, Aggarwal NT, Shah RC, Wilson RS (2006) Neuropathology of older persons without cognitive impairment from two communitybased studies. Neurology 66, 1837-1844.
13. Yeoman M, Scutt G, Faragher R (2012) Insights into CNS ageing from animal models of senescence. Nat Rev Neurosci 13, 435-445.
14. Perl DP (2010) Neuropathology of Alzheimer's disease. Mt Sinai J Med 77, 32-42.
15. Wright AL, Zinn R, Hohensinn B, Konen LM, Beynon SB, Tan RP, Clark IA, Abdipranoto A, Vissel B (2013) Neuroinflammation and neuronal loss precede Abeta plaque deposition in the hAPP-J20 mouse model of Alzheimer's disease. PLoS One 8, e59586.
16. Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, Hu K, Kholodenko D, Johnson-Wood K, McConlogue L (2000) High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: Synaptotoxicity without plaque formation. J Neurosci 20, 4050-4058.
17. Harris JA, Devidze N, Halabisky B, Lo I, Thwin MT, Yu GQ, Bredesen DE, Masliah E, Mucke L (2010) Many neuronal and behavioral impairments in transgenic mouse models of Alzheimer's disease are independent of caspase cleavage of the amyloid precursor protein. J Neurosci 30, 372-381.
18. Karl T, Bhatia S, Cheng D, Kim WS, Garner B (2012) Cognitive phenotyping of amyloid precursor protein transgenic J20 mice. Behav Brain Res 228, 392-397.
19. Leuner B, Gould E (2010) Structural plasticity and hippocampal function. Annu Rev Psychol 61, 111-140, C111-113.
20. Moser MB,Moser EI (1998) Functional differentiation in the hippocampus. Hippocampus 8, 608-619.
21. Morris RG, Garrud P, Rawlins JN, O'Keefe J (1982) Place navigation impaired in rats with hippocampal lesions. Nature 297, 681-683.
22. Colombo M, Fernandez T, Nakamura K, Gross CG (1998) Functional differentiation along the anterior-posterior axis of the hippocampus in monkeys. J Neurophysiol 80, 1002-1005.
23. Pothuizen HH, Zhang WN, Jongen-Relo AL, Feldon J, Yee BK (2004) Dissociation of function between the dorsal and the ventral hippocampus in spatial learning abilities of the rat: A within-subject, within-task comparison of reference and working spatial memory. Eur J Neurosci 19, 705-712.
24. Beauquis J, Vinuesa A, Pomilio C, Pavia P, Galvan V, Saravia F (2014) Neuronal and glial alterations, increased anxiety and cognitive impairment before hippocampal amyloid deposition in PDAPP mice, model of Alzheimer's disease. Hippocampus 24, 257-269.
25. West MJ, Coleman PD, Flood DG, Troncoso JC (1994) Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 344, 769-772.
26. Bobinski M,Wegiel J, Tarnawski M, Bobinski M, Reisberg B, de Leon MJ, Miller DC,WisniewskiHM(1997) Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease. J Neuropathol Exp Neurol 56, 414-420.
27. Barres BA (2008) The mystery and magic of glia: A perspective on their roles in health and disease. Neuron 60, 430-440.
28. Cerbai F, Lana D, Nosi D, Petkova-Kirova P, Zecchi S, Brothers HM,Wenk GL, Giovannini MG (2012) The neuron-astrocyte-microglia triad in normal brain ageing and in a model of neuroinflammation in the rat hippocampus. PLoS One 7, e45250.
29. De Keyser J, Mostert JP, Koch MW (2008) Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders. J Neurol Sci 267, 3-16.
30. Ming GL, Song H (2011) Adult neurogenesis in the mammalian brain: Significant answers and significant questions. Neuron 70, 687-702.
31. Rietze R, Poulin P, Weiss S (2000) Mitotically active cells that generate neurons and astrocytes are present in multiple regions of the adult mouse hippocampus. J Comp Neurol 424, 397-408.
32. Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA, Gage FH (1998) Neurogenesis in the adult human hippocampus. Nat Med 4, 1313-1317.
33. Mullen RJ, Buck CR, Smith AM (1992) NeuN, a neuronal specific nuclear protein in vertebrates. Development 116, 201-211.
34. Scholzen T, Gerdes J (2000) The Ki-67 protein: From the known and the unknown. J Cell Physiol 182, 311-322.
35. Wojtowicz JM, Kee N (2006) BrdU assay for neurogenesis in rodents. Nat Protoc 1, 1399-1405.
36. Paxinos G, Franklin K (2013) The Mouse Brain in Stereotaxic Coordinates, Elsevier Academic Press, San Diego.
37. von Bohlen und HalbachO(2007) Immunohistological markers for staging neurogenesis in adult hippocampus. Cell Tissue Res 329, 409-420.
38. Friocourt G, Koulakoff A, Chafey P, Boucher D, Fauchereau F, Chelly J, Francis F (2003) Doublecortin functions at the extremities of growing neuronal processes. Cereb Cortex 13, 620-626.
39. Robinson SR, Bishop GM (2002) The search for an amyloid solution. Science 298, 962-964.
40. Schmitz C, Rutten BP, Pielen A, Schafer S, Wirths O, Tremp G, Czech C, Blanchard V, Multhaup G, Rezaie P, Korr H, Steinbusch HW, Pradier L, Bayer TA (2004) Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease. Am J Pathol 164, 1495-1502.
41. López-Toledano MA, Shelanski ML (2007) Increased neurogenesis in young transgenic mice overexpressing human APP(Sw, Ind). J Alzheimers Dis 12, 229-240.
42. Beynon SB, Walker FR (2012) Microglial activation in the injured and healthy brain: What are we really talking about? Practical and theoretical issues associated with the measurement of changes in microglial morphology. Neuroscience 225, 162-171.
43. Kauppinen TM, Suh SW, Higashi Y, Berman AE, Escartin C, Won SJ, Wang C, Cho SH, Gan L, Swanson RA (2011) Poly(ADP-ribose)polymerase-1 modulates microglial responses to amyloid beta. J Neuroinflammation 8, 152.
44. McEwen BS (1999) Stress and hippocampal plasticity. Annu Rev Neurosci 22, 105-122.
45. Snyder JS, Hong NS, McDonald RJ, Wojtowicz JM (2005) A role for adult neurogenesis in spatial long-term memory. Neuroscience 130, 843-852.
46. Zhang CL, Zou Y, He W, Gage FH, Evans RM (2008) A role for adult TLX-positive neural stem cells in learning and behaviour. Nature 451, 1004-1007.
47. Namba T, Mochizuki H, Onodera M, Mizuno Y, Namiki H, Seki T (2005) The fate of neural progenitor cells expressing astrocytic and radial glial markers in the postnatal rat dentate gyrus. Eur J Neurosci 22, 1928-1941.
48. Schlüter C, Duchrow M,Wohlenberg C, Becker MH, Key G, Flad HD, Gerdes J (1993) The cell proliferation-associated antigen of antibody Ki-67: A very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Biol 123, 513-522.
49. Lazarov O, Marr RA (2010) Neurogenesis and Alzheimer's disease: At the crossroads. Exp Neurol 223, 267-281.
50. Mu Y, Gage FH (2011) Adult hippocampal neurogenesis and its role in Alzheimer's disease. Mol Neurodegener 6, 85.
51. Stone SS, Teixeira CM, Devito LM, Zaslavsky K, Josselyn SA, Lozano AM, Frankland PW (2011) Stimulation of entorhinal cortex promotes adult neurogenesis and facilitates spatial memory. J Neurosci 31, 13469-13484.
52. Jin K, GalvanV, Xie L, Mao XO, Gorostiza OF, Bredesen DE, Greenberg DA (2004) Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APPSw, Ind) mice. Proc Natl Acad Sci U S A 101, 13363-13367.
53. Yu Y, He J, Zhang Y, Luo H, Zhu S, Yang Y, Zhao T, Wu J, Huang Y, Kong J, Tan Q, Li XM(2009) Increased hippocampal neurogenesis in the progressive stage of Alzheimer's disease phenotype in an APP/PS1 double transgenic mouse model. Hippocampus 19, 1247-1253.
54. Jin K, Peel AL, Mao XO, Xie L, Cottrell BA, Henshall DC, GreenbergDA(2004) Increased hippocampal neurogenesis in Alzheimer's disease. Proc Natl Acad Sci U S A 101, 343-347.
55. Haughey NJ, Nath A, Chan SL, Borchard AC, Rao MS, Mattson MP (2002) Disruption of neurogenesis by amyloid beta-peptide, and perturbed neural progenitor cell homeostasis, in models of Alzheimer's disease. J Neurochem 83, 1509-1524.
56. Brown JP, Couillard-Despres S, Cooper-Kuhn CM, Winkler J, Aigner L, Kuhn HG (2003) Transient expression of doublecortin during adult neurogenesis. JCompNeurol 467, 1-10.
57. Hsia AY, Masliah E, McConlogue L, Yu GQ, Tatsuno G, Hu K, Kholodenko D, Malenka RC, Nicoll RA, Mucke L (1999) Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc Natl Acad Sci U S A 96, 3228-3233.
58. Klein WL (2013) Synaptotoxic amyloid-beta oligomers: A molecular basis for the cause, diagnosis, and treatment of Alzheimer's disease? J Alzheimers Dis 33(Suppl 1), S49-S65.
59. Jin M, Shepardson N, Yang T, Chen G, Walsh D, Selkoe DJ (2011) Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc Natl Acad Sci U S A 108, 5819-5824.
60. Brosseron F, Krauthausen M, Kummer M, Heneka MT (2014) Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: A comparative overview. Mol Neurobiol, doi: 10.1007/s12035-014-8657-1.
61. Sierra A, Encinas JM, Maletic-SavaticM(2011) Adult human neurogenesis: From microscopy to magnetic resonance imaging. Front Neurosci 5, 47.
62. Laurén J (2014) Cellular prion protein as a therapeutic target in Alzheimer's disease. J Alzheimers Dis 38, 227-244.
63. Kim HJ, Chang KA, Ha TY, Kim J, Ha S, Shin KY, Moon C, Nacken W, Kim HS, Suh YH (2014) S100A9 knockout decreases the memory impairment and neuropathology in crossbreed mice of Tg2576 and S100A9 knockout mice model. PLoS One 9, e88924.
64. Grégoire CA, Bonenfant D, Le Nguyen A, Aumont A, Fernandes KJ (2014) Untangling the influences of voluntary running, environmental complexity, social housing and stress on adult hippocampal neurogenesis. PLoS One 9, e86237.
65. Rodriguez JJ, Noristani HN,VerkhratskyA(2013) Microglial response to Alzheimer's disease is differentially modulated by voluntary wheel running and enriched environments. Brain Struct Funct, doi: 10.1007/s00429-013-0693-5.